The novel vasopressin receptor (V1aR) antagonist SRX246 reduces anxiety in an experimental model in humans: a randomized proof-of-concept study

作者：Tiffany R. Lago, Michael Brownstein, Emily Page, Emily Beydler, Adrienne Manbeck, Alexis Beale, Camille Roberts, Nicholas L. Balderston, Eve Damiano, Suzanne L. Pineles, Neal G. Simon, Monique Ernst, Christian Grillon · 发表于：Psychopharmacology · 年份：2021 · DOI：10.1007/s00213-021-05861-4 · 被引用次数：37 · 研究领域：Neuroendocrine regulation and behavior、Stress Responses and Cortisol、Anesthesia and Neurotoxicity Research